Shen Yang, Shen Jun, Chen Yu, Zeng Xiao-Ying, Li Jun-Min, Ni Yu-Xing, Shen Zhi-Xiang
Department of Hematology, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China.
Zhonghua Xue Ye Xue Za Zhi. 2004 Jun;25(6):328-32.
To investigate the epidemiological characteristics and drug resistance profile of the infection in patients with hematological malignancies.
All the microbe strains isolated from the department of hematology in Ruijin hospital between 1998 and 2002 were collected for the assessment of antimicrobial susceptibility and the results were analysed by WHONET5 software.
Out of the 536 strains isolated in the department of hematology, 230 (42.9%) were Gram positive and 301 (56.2%) Gram negative organisms. The first 6 strains of Gram (-) microbes in frequent order were Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter cloacae, Escherichia coli, Acinetobacter Baumannii and Stenotrophomonas (xantho) maltophi. The extended spectrum beta-lactamase (ESBLs) producing rates of Escherichia coli and Klebsiella pneumoniae were 27.3% and 33.3%, respectively. Methylcillin resistant coagulase negative staphylococcus (MRCNS) was the most prevalent Gram (+) bacteria in the complicated infection patients with hematological malignancies, which accounted for 88.5%. Carbapenems were most sensitive for all of the gram negative bacteria, with a drug resistance rate of 11.4 (5.0% approximately 15.8%) of imipenem. For ESBLs strains, carbapenems and cefapime were the best choice, with the resistance rate of 46.4% approximately 94.4% and 50.0% approximately 75.9%, respectively. The drug resistance rate of Acinetobacter Baumannii was 25.0% approximately 41.3% for the third generation cephalosporin, 22.7% for the fourth generation cephalosporin and 12.7% for imipenem. Pseudomonas aeruginosa was resistant to carbapenems, with a resistance rate of 12.7% of imipenem; however, it was more sensitive to the third generation cephalosporin.
Antibiotics should be rationally administrated with more considerations to the characteristics of epidemiology and drug resistance profile of the microbes in the given department of hematology.
探讨血液系统恶性肿瘤患者感染的流行病学特征及耐药情况。
收集1998年至2002年上海交通大学医学院附属瑞金医院血液科分离出的所有微生物菌株,进行药敏评估,并采用WHONET5软件分析结果。
血液科分离出的536株菌株中,革兰阳性菌230株(42.9%),革兰阴性菌301株(56.2%)。革兰阴性菌前6位依次为铜绿假单胞菌、肺炎克雷伯菌、阴沟肠杆菌、大肠埃希菌、鲍曼不动杆菌和嗜麦芽窄食单胞菌。大肠埃希菌和肺炎克雷伯菌产超广谱β-内酰胺酶(ESBLs)率分别为27.3%和33.3%。耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)是血液系统恶性肿瘤合并感染患者中最常见的革兰阳性菌,占88.5%。碳青霉烯类对所有革兰阴性菌最敏感,亚胺培南耐药率为11.4%(5.0%~15.8%)。对于产ESBLs菌株,碳青霉烯类和头孢吡肟是最佳选择,耐药率分别为46.4%~94.4%和50.0%~75.9%。鲍曼不动杆菌对第三代头孢菌素耐药率为25.0%~41.3%,对第四代头孢菌素耐药率为22.7%,对亚胺培南耐药率为12.7%。铜绿假单胞菌对碳青霉烯类耐药,亚胺培南耐药率为12.7%;但对第三代头孢菌素较敏感。
应结合血液科微生物的流行病学特征及耐药情况合理使用抗生素。